Which of the following best describes neologism?

A. Overreaction of a medical symptom. While individuals with illness anxiety disorder (IAD) may misinterpret normal bodily sensations as signs of serious illness, the key feature is excessive health-related worry in the absence of significant symptoms, rather than just overreacting to existing symptoms.

B. Faked symptoms. Feigning symptoms is characteristic of factitious disorder (formerly Munchausen syndrome) or malingering, where individuals intentionally produce or exaggerate symptoms for attention or external gain. In IAD, the concern is genuine but unfounded, rather than intentionally fabricated.

C. Abnormal voluntary motor or sensory dysfunction. This describes conversion disorder (functional neurological symptom disorder), where individuals experience neurological symptoms (e.g., paralysis, blindness, or seizures) without a medical explanation, typically triggered by psychological stress.

D. Worry about health despite no symptoms. Illness anxiety disorder (IAD) is marked by persistent, excessive fear of having a serious illness, despite minimal or no symptoms and repeated medical reassurance. Patients often engage in excessive health-related behaviors (e.g., frequent doctor visits, checking their body) or avoid medical care altogether due to fear of diagnosis.

A. Clozapine (Clozaril) is a second-generation (atypical) antipsychotic known for its strong dopamine (D2) and serotonin (5-HT2A) blockade. It is primarily used for treatment-resistant schizophrenia but has a high risk of agranulocytosis, metabolic syndrome, and sedation, requiring regular blood monitoring.

B. Haloperidol (Haldol) is a first-generation (typical) antipsychotic that strongly blocks dopamine (D2) receptors, leading to a high risk of extrapyramidal symptoms (EPS) such as dystonia, tardive dyskinesia, and akathisia. It is commonly used for acute psychosis and agitation.

C. Fluphenazine (Prolixin is a first-generation antipsychotic that also strongly antagonizes D2 receptors, making it effective for chronic schizophrenia but highly associated with EPS. It is available in long-acting injectable (LAI) form for maintenance therapy.

D. Chlorpromazine (Thorazine) is a first-generation, low-potency antipsychotic with strong sedative, anticholinergic, and hypotensive effects. While it has a lower risk of EPS compared to high-potency FGAs like haloperidol, it causes more sedation, orthostatic hypotension, and weight gain due to histamine and muscarinic receptor blockade.